ClariTrial | Search Clinical Trials

blood-oxygen-level-dependent functional magnetic resonance imagingdynamic contrast-enhanced magnetic resonance imagingmagnetic resonance spectroscopic imaging+1 more

University of Texas Southwestern Medical Center0Completes Sep 2011

Compare CT.gov Full analysis →

Completed

Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

N/AProstate Tumor

remimazolamPropofol

Yonsei University112 participants1 site · South KoreaCompletes Oct 2024

Compare CT.gov Full analysis →

Completed

Results posted

Global Performance Evaluation of the AMS CONTINUUM™ Device

Phase 4Prostate Cancer

CONTINUUM™

American Medical Systems10 participants2 sites · Greece, SpainCompletes Nov 2010

Compare CT.gov Full analysis →

Recruiting

An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors

Phase 1Phase 2Advanced Solid TumorsPARP Inhibitor

SRP1020

Shanghai SciBrunch Therapeutics Co., Ltd.210 participants2 sites · ChinaCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With Glioma

Phase 2WHO Grade 3 GliomaWHO Grade 4 Glioma

Computed TomographyElectronic Health Record ReviewGa 68 PSMA-11+1 more

Mayo Clinic25 participants1 site · United StatesCompletes Jul 2028

Compare CT.gov Full analysis →

Completed

Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)

N/ABenign Prostatic Hyperplasia

Microspheres

University of North Carolina, Chapel Hill15 participants1 site · United StatesCompletes May 2017

Compare CT.gov Full analysis →

UNKNOWN

TNFerade Biologic to Treat Locally Advanced Prostate Cancer

Phase 1Locally Advanced Prostate Cancer

TNFerade™ Biologic

GenVec20 participants1 site · United States

Compare CT.gov Full analysis →

1–15 of 8,651

Explore/Prostate Cancer

Status

Phase

8,651 results for “Prostate Cancer”

Page 1 of 577

Recruiting

PET/CT Characterization of Treatment Resistance

N/AProstate Cancer

F-fluorodeoxyglucose positron emission tomography (FDG PET)prostate-specific membrane antigen positron emission tomography (PSMA PET)

University of Wisconsin, Madison25 participants1 site · United StatesCompletes Sep 2026

Compare CT.gov Full analysis →

Active

Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test

N/AHuman Papilloma Virus

ScreenFire HPV testcareHPV testColposcopy and biopsy+2 more

The Cleveland Clinic9,100 participants1 site · El SalvadorCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Phase 1Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer

DR-0202

Dren Bio96 participants10 sites · United StatesCompletes Jul 2027

Compare CT.gov Full analysis →

Completed

Results posted

RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers

Phase 2Prostate Cancer

Radium-223stereotactic ablative radiotherapy (SABR)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins64 participants1 site · United StatesCompletes Jul 2025

Compare CT.gov Full analysis →

Active

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

Phase 2Prostate Cancer

questionnaire administrationquality-of-life assessmentimage-guided radiation therapy+2 more

Cancer Trials Ireland251 participants5 sites · IrelandCompletes May 2026

Compare CT.gov Full analysis →

Completed

Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention

N/AProstate Cancer

Preferred music listeningRelaxation breathing narrative over hypnotic music listening

Johns Hopkins University77 participants1 site · United StatesCompletes Dec 2020

Compare CT.gov Full analysis →

Completed

Results posted

A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)

Phase 2Prostate Cancer

NivolumabIpilimumabCabazitaxel+1 more

Bristol-Myers Squibb351 participants59 sites · United States, Australia, AustriaCompletes Apr 2022

Compare CT.gov Full analysis →

Completed

Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy

N/AProstate CancerPost-Prostatectomy

Transperineal Ultrasound

University of Vermont Medical Center15 participants1 site · United StatesCompletes Jan 2016

Compare CT.gov Full analysis →

Withdrawn

MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy

N/AProstate Cancer

blood-oxygen-level-dependent functional magnetic resonance imagingdynamic contrast-enhanced magnetic resonance imagingmagnetic resonance spectroscopic imaging+1 more

University of Texas Southwestern Medical Center0Completes Sep 2011

Compare CT.gov Full analysis →

Completed

Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy

N/AProstate Tumor

remimazolamPropofol

Yonsei University112 participants1 site · South KoreaCompletes Oct 2024

Compare CT.gov Full analysis →

Completed

Results posted

Global Performance Evaluation of the AMS CONTINUUM™ Device

Phase 4Prostate Cancer